SeaStar Medical Holding Corporation ICU
3.42
(0.02)
(0.58%)
as of 25 Sep
- Market cap
- $15.2M
- P/E
- 0.0×
Follow ICU
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
8.75 | 10.15 | 4.03 | 17.08 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(5.01) | (5.28) | (1.22) | (3.91) | |
P/B ratio |
3.49 | 1.99 | 0.48 | 1.31 | |
Price to Tangible BV |
3.49 | 1.99 | 0.48 | 1.31 | |
EV/Sales |
6.18 | 5.43 | (3.60) | 4.37 | |
EV/EBITDA |
0.00 | 0.00 | 0.37 | 0.00 | |
EV/Operating CF |
(0.77) | (0.57) | 0.33 | (0.27) | |
EV/FCF |
(0.77) | (0.57) | 0.33 | (0.27) | |
Quick Ratio |
1.65 | 2.41 | 3.26 | 3.44 | |
Current Ratio |
1.89 | 2.73 | 3.63 | 3.66 | |
Net Debt/EBITDA |
1.84 | 2.60 | 3.97 | 3.85 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.20 | 0.15 | 0.13 | 0.09 | |
Operating CF/Net income |
0.80 | 0.78 | 1.41 | 1.11 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
409.76% | 473.54% | 523.81% | 1,010.93% | |
Selling, General and Administrative Expense of Revenue |
297.89% | 345.05% | 291.90% | 1,037.16% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
(16.10%) | 18.38% | 16.67% | 158.47% | |
Graham Net Nets |
0.26 | 0.47 | 1.98 | 0.72 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(106.54%) | (129.03%) | (345.83%) | (289.47%) | |
Free Cash Flow Yield |
(91.36%) | (94.04%) | (273.34%) | (94.38%) | |
Revenue per Share |
0.15 | 0.13 | 0.20 | 0.07 | |
Operating CF per Share |
(0.73) | (0.70) | (1.97) | (1.46) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.73) | (0.70) | (1.97) | (1.46) | |
Cash per Share |
1.70 | 2.39 | 5.78 | 5.21 | |
Shareholders Equity per Share |
1.05 | 1.87 | 5.02 | 4.34 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.05 | 1.87 | 5.02 | 4.34 | |
Free Cash Flow |
(2.99) | (2.76) | (4.09) | (3.84) | |
Working Capital |
3.88 | 6.82 | 9.84 | 10.81 | |
Net Current Asset Value |
3.88 | 6.82 | 9.84 | 10.81 | |
EV/EBIT |
0.00 | 0.00 | 0.36 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(606.50%) | (711.31%) | (691.43%) | (1,897.27%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.21 | 0.14 | 0.17 | 0.14 | |
Average Payables |
1.95 | 2.06 | 2.00 | 2.85 | |
Average Inventory |
0.08 | 0.05 | — | — | |
Average Assets |
8.52 | 9.43 | 9.41 | 10.06 | |
Average Common Equity |
3.82 | 3.94 | 4.12 | 4.71 |
Columns are period end dates